Lysosomal protease cathepsin D is a prognostic marker in endometrial cancer
1996

Cathepsin D as a Prognostic Marker in Endometrial Cancer

Sample size: 115 publication Evidence: high

Author Information

Author(s): A Losch, P Kohlberger, G Gitsch, A Kaider, G Breitenecker, Ch Kainz

Primary Institution: University of Vienna

Hypothesis

The study investigates the prognostic value of cathepsin D expression in endometrial adenocarcinoma.

Conclusion

Cathepsin D expression is a significant prognostic marker for overall survival in patients with endometrial adenocarcinoma.

Supporting Evidence

  • 35 out of 115 cases showed positive cathepsin D expression.
  • Cathepsin D expression was found to have significant prognostic value for overall survival.
  • In multivariate analysis, cathepsin D had an independent prognostic value with a relative risk of 3.8.

Takeaway

This study found that a protein called cathepsin D can help doctors predict how well patients with a certain type of cancer will do after treatment.

Methodology

Immunohistochemistry was used to detect cathepsin D in tissue specimens from patients with endometrial adenocarcinoma.

Limitations

Lymph node staging was not performed routinely, limiting the analysis of its correlation with cathepsin D expression.

Participant Demographics

Mean age of participants was 64.3 years, with a range from 36 to 85 years; seven patients were premenopausal.

Statistical Information

P-Value

0.002

Confidence Interval

1.4 - 10.0

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication